Macquarie Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-470,345
Closed -$12.7M 1705
2025
Q2
$12.7M Buy
470,345
+22,109
+5% +$640K 0.02% 765
2025
Q1
$13.3M Sell
448,236
-24,196
-5% -$922K 0.02% 757
2024
Q4
$18.7M Sell
472,432
-238,930
-34% -$9.05M 0.02% 665
2024
Q3
$24.2M Buy
+711,362
New +$20M 0.03% 623
2022
Q4
Sell
-261,490
Closed -$4.35M 2132
2022
Q3
$4.35M Sell
261,490
-394,761
-60% -$8.88M 0.01% 1017
2022
Q2
$13.1M Buy
656,251
+70,933
+12% +$1.43M 0.01% 804
2022
Q1
$16.1M Sell
585,318
-614
-0.1% -$17.6K 0.01% 823
2021
Q4
$24.1M Sell
585,932
-4,490
-0.8% -$198K 0.02% 706
2021
Q3
$27.4M Buy
590,422
+7,030
+1% +$307K 0.02% 683
2021
Q2
$23.3M Buy
583,392
+580,713
+21,676% +$24.8M 0.02% 741
2021
Q1
$144K Buy
2,679
+1,142
+74% +$65.8K ﹤0.01% 1804
2020
Q4
$75K Hold
1,537
﹤0.01% 1940
2020
Q3
$50K Hold
1,537
﹤0.01% 1957
2020
Q2
$40K Buy
+1,537
New +$38.3K ﹤0.01% 1983

Other funds holding VCYT

Macquarie Group's VCYT Position: Q3 2025 in Review

Macquarie Group sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 470,345 shares — an estimated $12.7M sold.

Macquarie Group first reported a position in VCYT in Q2 2020 and held it in 14 quarters. The position peaked at $27.4M in Q3 2021. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Macquarie Group reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Macquarie Group sold 470,345 Veracyte shares in Q3 2025, an estimated $12.7M.
  • Macquarie Group first reported a position in Veracyte in Q2 2020 and held it in 14 quarters.
  • Macquarie Group's Veracyte position peaked at $27.4M in Q3 2021.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Macquarie Group's 13F filing for Q3 2025, filed 13 Nov 2025.